Clinical trial NCT05273021: Validation of the Dutch Translation of the Tobacco, Alcohol, Prescription Medication and Other Substances (TAPS)-Tool
Official title: Implementation and Validation of the Dutch Translation of the TAPS-tool: a Screener for Tobacco, Alcohol, Prescription Medication and Other Substances for Patients With Severe Mental Illness With and Without Intellectual Disability
Study type: OBSERVATIONAL
Overall status: RECRUITING
Conditions: Substance Use
Severe Mental Disorder
Intellectual Disability, Mild
Keywords: TAPS
screener
Lead sponsor: Radboud University Medical Center
Sponsor class: OTHER
Collaborators: name: Ggz Oost Brabant
First posted: 2022-03-10
Enrollment: 150
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Observational model: CASE_ONLY
Time perspective: CROSS_SECTIONAL
Sampling method: PROBABILITY_SAMPLE
Study population: secondary psychiatric care departments and special services for people with intellectual disabilities

Brief summary: The aim of the study is to investigate the reliability and validity of the Dutch version of the TAPS-tool.

This will be investigated in 2 groups: patients without intellectual disabilities treated in Flexible Assertive Community Treatment (FACT) teams and patients with intellectual disabilities. For the later group, an adjusted version of the TAPS-tool will be developed.

For both groups the TAPS outcome will be compared to a golden standard.

Detailed description: All FACT teams in the participating organization (GGZ Oost Brabant) work through a standardized care pattern which implicates screening and assessment on several areas. At the start of the treatment all patients are assessed for intellectual disabilities, trauma related symptoms, addiction, quality of life, level of psychiatric complaints, social functioning, and phase of recovery. Subsequently quality of life and the level of psychiatric complaints is measured yearly. For this research question a small golden standard instrument was added to the standard screening and assessment.

For people with intellectual disabilities (ID) who get an extensive assessment of substance use problems in their (standard) treatment, permission to participate on the TAPS (version for ID) was asked.

Eligibility criteria: Inclusion Criteria:

* All patients treated in the participating FACT teams and for patients treated at the LVB-P (department for patients with intellectual disabilities and psychiatric disorders \[Dutch name\]) department of the GGZ Oost Brabant or the ORO foundation (ORO is no abbreviation but just a name of the institute).

Exclusion Criteria:

* If patients do not have sufficient command of the Dutch language or cannot concentrate for 20 minutes, the instruments are not taken

Primary outcomes:
measure: TAPS
timeFrame: one assessment at the start of the treatment
measure: Measurement of Addiction for Triage and Evaluation (MATE)
timeFrame: At the start of FACT treatment, only for participants of this study
measure: Substance use measurement for people with intellectual disabilities (SumID-Q)
timeFrame: Standard assessment at the start of the treatment, or when substance use problems are suspected
Secondary outcomes:
measure: Health of the Nation Outcome Scales (HoNOS)
timeFrame: Once at start of FACT treatment
measure: Manchester abbreviated quality of life measure (MANSA)
timeFrame: Once, at start of FACT treatment
Other outcomes:
Locations:
city: Boekel
country: Netherlands
facility: GGZ Oost Brabant - FACT
state: Noord Brabant
city: Boekel
country: Netherlands
facility: GGZ Oost Brabant - LVB-P
state: Noord Brabant
city: Helmond
country: Netherlands
facility: Stichting ORO
state: Noord Brabant
Study officials:
References: